Red Rock Pharmacy
- Pharmacy Profile Name: Red Rock Pharmacy
- Website: redrockrx.com
- Locations: Salt Lake City, UT (HQ); Springville, UT; St. George, UT
- Pharmacy Type: Multi-location pharmacy — long-term care pharmacy + 503A compounding
- GLP-1 Products: Semaglutide, High-dose Semaglutide, Tirzepatide, Tirzepatide/Semaglutide combination, Sermorelin, NAD+, Glutathione, GAC, Vitamins
- Licensed: Springville location — all states except AL, AR, CA, LA, MS, NV; St. George location — CA and NV only
- Telehealth Partners: Mochi Health, Fridays, Zappy Health
About the Pharmacy
Red Rock Pharmacy is a growing business originally based in Salt Lake City, Utah, that has expanded to cover the Intermountain West. It services skilled nursing facilities, assisted living facilities, intermediate care facilities, and other long-term care communities, with long-standing success in the long-term care arena built on relationships with customers and a joint commitment to patient care.
Red Rock Pharmacy operates locations in Salt Lake City, Springville, and St. George, Utah.
What makes Red Rock a distinctive entry in the GLP-1 compounding space is that it is fundamentally a long-term care pharmacy that has built out a separate compounding operation to serve the telehealth weight loss market. The Springville location handles the bulk of national telehealth GLP-1 fulfillment, while the St. George location holds California and Nevada licenses specifically. This two-location licensing structure allows Red Rock to serve patients in states that require separate pharmacy registration, extending its GLP-1 reach to all states except Alabama, Arkansas, Louisiana, Mississippi — and California and Nevada are covered through St. George rather than Springville.
GLP-1 Compounding
Red Rock Pharmacy’s Springville location offers Semaglutide, Tirzepatide, High-dose Semaglutide, Tirzepatide/Semaglutide combination, Sermorelin, NAD+, Glutathione, GAC, and Vitamins, all licensed in all states except Alabama, Arkansas, California, Louisiana, Mississippi, and Nevada. Its St. George location offers Semaglutide, High-dose Semaglutide, Tirzepatide, NAD+, and Sermorelin, licensed specifically for California and Nevada.
The Tirzepatide/Semaglutide combination product is a less common offering — most compounders offer each separately — and reflects a degree of formulation flexibility. The High-dose Semaglutide offering as a distinct SKU from standard Semaglutide suggests Red Rock caters to patients requiring higher-than-standard dose concentrations, a common need among longer-term GLP-1 users.
Type of Pharmacy
Red Rock Pharmacy operates as a 503A state-licensed compounding pharmacy across its Springville and St. George locations for GLP-1 fulfillment. Its Salt Lake City headquarters primarily serves the long-term care market. No PCAB or NABP compounding accreditation was found in publicly available records as of March 2026.
No FDA Warning Letter or enforcement action targeting Red Rock Pharmacy was found in FDA public records as of March 2026. An early 2025 report noted that Red Rock Pharmacy issued a notice to its prescriber network regarding a former employee who had been contacting Red Rock customers to promote compounded semaglutide and tirzepatide from a competitor pharmacy at lower prices — a situation in which Red Rock was the victim of the solicitation, not the subject of any enforcement action.
States Licensed In
The Springville location ships to all states except Alabama, Arkansas, California, Louisiana, Mississippi, and Nevada. The St. George location covers California and Nevada. This means Red Rock can collectively reach most of the country, with Alabama, Arkansas, Louisiana, and Mississippi remaining outside its GLP-1 dispensing footprint.
Telehealth Providers They Work With
Red Rock Pharmacy’s GLP-1 patient volume runs heavily through Mochi Health. Patient social media is dense with Mochi Health members referencing Red Rock as their assigned pharmacy, including unboxing videos and milestone updates. Patient accounts on social media document receiving tirzepatide from Red Rock Pharmacy through Mochi Health, noting the medication arriving in 7 days with temperature control packaging, syringes, and detailed instructions, and that Mochi Health and Red Rock resolved an issue within 48 hours.
Beyond Mochi Health, Red Rock is also a confirmed pharmacy partner for Fridays (the GLP-1 telehealth platform) and Zappy Health, based on patient accounts and platform-level references across social media and patient forums.
Pricing from Reviews
Pricing for Red Rock’s compounded GLP-1 products flows through the prescribing telehealth platform rather than appearing as retail pricing from Red Rock directly. Patients accessing Red Rock through Mochi Health, Fridays, or Zappy Health pay those platforms’ published rates, with pharmacy costs embedded in the program fee. No independent pricing list from Red Rock is publicly available.
Overall Reviews
Patient sentiment toward Red Rock Pharmacy in the GLP-1 community is predominantly positive. Patients on social media consistently report fast shipping, good temperature-controlled packaging with syringes and instructions included, and responsive service when issues arise. The Mochi Health/Red Rock pairing in particular has a strong reputation in patient forums for reliable fulfillment and responsive issue resolution. No significant safety complaints, contamination reports, or efficacy concerns were found in public records as of March 2026.
The one notable sentiment in patient accounts is the standard 3-month beyond-use date on vials, which some patients find limiting but is standard for 503A sterile compounding.





